CAS 347887-36-9

Fedovapagon

CAS: 347887-36-9

Formel: C₂₇H₃₄N₄O₃

Reinheit: 97%

Farbe und Form: Solid

Molekulargewicht: 462.5839

Ref: IN-DA01E48H

Fedovapagon

CAS: 347887-36-9

Fedovapagon

Reinheit: ≥98%

Molekulargewicht: 462.58g/mol

Ref: 54-BUP06213

(S)-N2,N2-Dimethyl-N1-(2-Methyl-4-(2,3,4,5-Tetrahydro-1H-Benzo[B]Azepine-1-Carbonyl)Benzyl)Pyrrolidine-1,2-Dicarboxamide

CAS: 347887-36-9

(S)-N2,N2-Dimethyl-N1-(2-Methyl-4-(2,3,4,5-Tetrahydro-1H-Benzo[B]Azepine-1-Carbonyl)Benzyl)Pyrrolidine-1,2-Dicarboxamide

Reinheit: 97%

Molekulargewicht: 462.58g/mol

Ref: 54-OR1024166

Fedovapagon

CAS: 347887-36-9

Fedovapagon (VA106483) is a pressin V2 receptor (V2R) agonist for the study of overactive bladder syndrome.

Formel: C₂₇H₃₄N₄O₃

Reinheit: 99.33%

Farbe und Form: Solid

Molekulargewicht: 462.58

Ref: TM-T15273

Fedovapagon

CAS: 347887-36-9

Fedovapagon is a synthetic drug that is used in the treatment of urinary incontinence. It is administered orally or nasally. Fedovapagon has been shown to be effective in the treatment of symptoms of male and female urinary incontinence. This medication also has a bond-cleaving activity, which facilitates its passage through the blood-brain barrier and its ability to cross the blood-brain barrier. It has been found to increase levels of brain serotonin and dopamine, which are neurotransmitters that control mood, appetite, and sexual behavior. Fedovapagon has also been shown to decrease levels of prostaglandin E2, which may play a role in controlling bladder contractions.

Formel: C₂₇H₃₄N₄O₃

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 462.58 g/mol

Ref: 3D-XNA88736

Fedovapagon

Kontrolliertes Produkt

CAS: 347887-36-9

Formel: C₂₇H₃₄N₄O₃

Farbe und Form: Neat

Molekulargewicht: 462.584

Ref: TR-F229080